Fresenius Medical Care AG FMS
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 84.71% | -63.88% | 18.51% | 25.66% | 60.66% |
| Total Depreciation and Amortization | 0.32% | 19.63% | -17.35% | 1.93% | 2.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -110.86% | -29.21% | 700.09% | 121.92% | -824.38% |
| Change in Net Operating Assets | 182.51% | -335.35% | 72.04% | -67.66% | 178.95% |
| Cash from Operations | 276.93% | -77.23% | 34.50% | -1.42% | 413.28% |
| Capital Expenditure | -25.73% | 54.84% | -119.13% | -28.25% | -14.23% |
| Sale of Property, Plant, and Equipment | 62.94% | -38.82% | 1,588.35% | -96.10% | 145.23% |
| Cash Acquisitions | 59.06% | -238.96% | 205.95% | 64.77% | -60.47% |
| Divestitures | -145.13% | -96.00% | -73.26% | 13,357.32% | -93.73% |
| Other Investing Activities | -257.91% | 149.17% | -1,586.77% | -120.33% | -36.30% |
| Cash from Investing | -58.81% | 59.27% | -671.10% | 60.84% | -41.54% |
| Total Debt Issued | 158.63% | -65.27% | 585.06% | -93.41% | 937.82% |
| Total Debt Repaid | -214.04% | 10.81% | 68.66% | -21.96% | -199.69% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 58.36% | 20.00% | -187.30% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 100.00% | -- |
| Other Financing Activities | -7.25% | -20.89% | 84.22% | -736.02% | 24.00% |
| Cash from Financing | -75.42% | -110.33% | 81.72% | -1,576.15% | 161.56% |
| Foreign Exchange rate Adjustments | -88.82% | 158.44% | -97.57% | 76.36% | -239.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.87% | -205.51% | 173.60% | -174.50% | 748.72% |